Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit-Reference-Cited by-同舟云学术

Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit

Published:2006-11 Issue:6 Volume:12 Page:531-535
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast Journal

Author:

Kurian Sobha,Qazilbash Muzzafar,Fay Joseph,Wolff S.,Herzig Roger,Hobbs Gerry,Bunner Pam,Weisenborn Robin,Aya-ay Melanie,Lynch Joseph,Ericson Solveig

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1524-4741.2006.00341.x/fullpdf

Reference16 articles.

1. High-dose chemotherapy for breast cancer: is another look warranted?

2. Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data

3. Predicting outcome based on swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the use of targeted agents in advanced gastroesophageal cancer increase complete response? A meta-analysis of 18 randomized controlled trials;Cancer Management and Research;2018-11

2. Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation;European Journal of Cancer;2016-04

3. Does the addition of targeted biological agents to first-line chemotherapy for advanced colorectal cancer increase complete response? A systematic review and meta-analysis;Colorectal Disease;2014-08-13

4. Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials;Cancer Treatment Reviews;2014-03

5. Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression;Science Translational Medicine;2014-01